Search research articles
Contact Us
Filters
Showing results (311-320 of 343) with videos related to
Page
of 35
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 18, 2023
Systemic Light Chain Amyloidosis, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology
Shaji K Kumar, Natalie S Callander, Kehinde Adekola, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 7, 2020
Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology
Shaji K Kumar, Natalie S Callander, Kehinde Adekola, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 6, 2022
NCCN Guidelines® Insights: Multiple Myeloma, Version 3.2022
Natalie S Callander, Muhamed Baljevic, Kehinde Adekola, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2019
Progression Risk Stratification of Asymptomatic Waldenström Macroglobulinemia
Mark Bustoros, Romanos Sklavenitis-Pistofidis, Prashant Kapoor, et al.
The New England Journal of Medicine
|
April 9, 2015
Ibrutinib in previously treated Waldenström's macroglobulinemia
Steven P Treon, Christina K Tripsas, Kirsten Meid, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 10, 2020
A Multi-Institutional Validation of the Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Patients With Diffuse Large B-Cell Lymphoma: A Study From The Latin American Group of Lymphoproliferative Disorders (GELL)
Brady E Beltrán, Luis Villela, Maria A Torres, et al.
Blood Advances
|
March 15, 2022
High frequency of central nervous system involvement in transformed Waldenström macroglobulinemia
Eric Durot, Lukshe Kanagaratnam, Saurabh Zanwar, et al.
Blood Advances
|
January 7, 2026
POD24 is a Novel Determinant of Prognosis in Patients with Waldenström Macroglobulinemia
Saurabh Zanwar, Jithma P Abeykoon, Shirley D'Sa, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 8, 2019
NCCN Guidelines Insights: Multiple Myeloma, Version 1.2020
Shaji K Kumar, Natalie S Callander, Jens Hillengass, et al.
Seminars in Hematology
|
April 26, 2023
Report of consensus panel 1 from the 11<sup>th</sup> International Workshop on Waldenstrom's Macroglobulinemia on management of symptomatic, treatment-naïve patients
Christian Buske, Jorge J Castillo, Jithma Prasad Abeykoon, et al.
Page
of 35
Search research articles
Search
Showing results (311-320 of 343) with videos related to
Sort By:
Page
of 35
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 18, 2023
Systemic Light Chain Amyloidosis, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology
Shaji K Kumar, Natalie S Callander, Kehinde Adekola, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 7, 2020
Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology
Shaji K Kumar, Natalie S Callander, Kehinde Adekola, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 6, 2022
NCCN Guidelines® Insights: Multiple Myeloma, Version 3.2022
Natalie S Callander, Muhamed Baljevic, Kehinde Adekola, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2019
Progression Risk Stratification of Asymptomatic Waldenström Macroglobulinemia
Mark Bustoros, Romanos Sklavenitis-Pistofidis, Prashant Kapoor, et al.
The New England Journal of Medicine
|
April 9, 2015
Ibrutinib in previously treated Waldenström's macroglobulinemia
Steven P Treon, Christina K Tripsas, Kirsten Meid, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 10, 2020
A Multi-Institutional Validation of the Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Patients With Diffuse Large B-Cell Lymphoma: A Study From The Latin American Group of Lymphoproliferative Disorders (GELL)
Brady E Beltrán, Luis Villela, Maria A Torres, et al.
Blood Advances
|
March 15, 2022
High frequency of central nervous system involvement in transformed Waldenström macroglobulinemia
Eric Durot, Lukshe Kanagaratnam, Saurabh Zanwar, et al.
Blood Advances
|
January 7, 2026
POD24 is a Novel Determinant of Prognosis in Patients with Waldenström Macroglobulinemia
Saurabh Zanwar, Jithma P Abeykoon, Shirley D'Sa, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 8, 2019
NCCN Guidelines Insights: Multiple Myeloma, Version 1.2020
Shaji K Kumar, Natalie S Callander, Jens Hillengass, et al.
Seminars in Hematology
|
April 26, 2023
Report of consensus panel 1 from the 11<sup>th</sup> International Workshop on Waldenstrom's Macroglobulinemia on management of symptomatic, treatment-naïve patients
Christian Buske, Jorge J Castillo, Jithma Prasad Abeykoon, et al.
Page
of 35